These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2522065)

  • 1. The effect of chronic gonadotropin-releasing hormone analog (D-Trp-6) treatment on elevated and normal serum prolactin levels.
    Golan A; Bukovsky I; Weinraub Z; Ron-El R; Herman A; Raziel A; Caspi E
    Fertil Steril; 1989 Mar; 51(3):532-4. PubMed ID: 2522065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptorelin to prevent hysterectomy in patients with leiomyomas.
    van Leusden HA
    Lancet; 1988 Aug; 2(8609):508. PubMed ID: 2900426
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
    Kessel B; Liu J; Mortola J; Berga S; Yen SS
    Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leiomyomas.
    Golan A; Bukovsky I; Schneider D; Ron-el R; Herman A; Caspi E
    Fertil Steril; 1989 Sep; 52(3):406-11. PubMed ID: 2528476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.
    Filicori M; Hall DA; Loughlin JS; Rivier J; Vale W; Crowley WF
    Am J Obstet Gynecol; 1983 Nov; 147(6):726-7. PubMed ID: 6356927
    [No Abstract]   [Full Text] [Related]  

  • 6. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
    Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-Trp-6-luteinizing hormone-releasing hormone inhibits hyperprolactinemia in female rats.
    Debeljuk L; Torres-Alemán I; Schally AV
    Endocrinology; 1985 Jun; 116(6):2227-31. PubMed ID: 3158510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH.
    van Leusden HA
    Lancet; 1986 Nov; 2(8517):1213. PubMed ID: 2877341
    [No Abstract]   [Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
    Neuman M; Langer R; Golan A; Bukovsky I; Caspi E; Koch Y
    Fertil Steril; 1991 Aug; 56(2):364-6. PubMed ID: 1649060
    [No Abstract]   [Full Text] [Related]  

  • 10. Complication of triptorelin treatment for uterine myomas.
    Ellenbogen A; Shulman A; Libal Y; Jaschevatzky O; Anderman S; Grunstein S
    Lancet; 1989 Jul; 2(8655):167-8. PubMed ID: 2567943
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
    Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
    Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
    Perl V; Marquez J; Schally AV; Comaru-Schally AM; Leal G; Zacharias S; Gomez-Lira C
    Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience in the treatment of fibroids with leuprolide and other GnRH agonists.
    Friedman AJ
    Obstet Gynecol Surv; 1989 May; 44(5):311-3. PubMed ID: 2498793
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of decapeptyl (D-TrpG GnPh) on estrogen receptors, progesterone receptors and tissue levels of estrogens (non-conjugated and sulfate-conjugated) in patients with uterine myoma].
    Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
    Pathol Biol (Paris); 1990 Nov; 38(9):941-3. PubMed ID: 2148976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
    Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone agonists: utilization before hysterectomy.
    Stovall TG
    Clin Obstet Gynecol; 1993 Sep; 36(3):642-9. PubMed ID: 8403610
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma.
    Waibel-Treber S; Minne HW; Scharla SH; Bremen T; Ziegler R; Leyendecker G
    Hum Reprod; 1989 May; 4(4):384-8. PubMed ID: 2526152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri.
    Coddington CC; Collins RL; Shawker TH; Anderson R; Loriaux DL; Winkel CA
    Fertil Steril; 1986 May; 45(5):624-9. PubMed ID: 3084300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide.
    Lubich LM; Alderman MG; Ros PR
    Magn Reson Imaging; 1991; 9(3):331-4. PubMed ID: 1908932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.